Obesity Surgery

, Volume 23, Issue 5, pp 650–656 | Cite as

Overweight Patients Achieve Ideal Body Weight Following Curative Gastrectomy Resulting in Better Long-Term Prognosis

  • Fanming Kong
  • Hui Li
  • Yongli Fan
  • Xinwei Zhang
  • Shui Cao
  • JinPu Yu
  • Xiubao RenEmail author
  • Xishan HaoEmail author
Original Contributions



The relationship between body mass index (BMI) and long-term outcome in gastric cancer patients following radical gastrectomy continues to be debated. We investigated the association between BMI, clinicopathological features, and prognosis in Chinese gastric carcinoma patients.


A retrospective consecutive cohort study was performed on 1,296 patients who underwent gastrectomy with curative intent at the Tianjin Cancer Institute Hospital between 1999 and 2004. The clinicopathological characteristics, overall 5-year survival rate (OS), and preoperative and six-month postoperative BMIs of both overweight (BMI ≥25 kg/m2; H-BMI; n = 364) and non-overweight (BMI <25 kg/m2; N-BMI; n = 932) patients were compared.


Among these patients, 364 (28.1 %) were overweight. The OS was significantly higher in the H-BMI than N-BMI group (33.2 vs. 24.1 %, respectively; p < 0.001). Preoperative and six-month postoperative BMIs were 27.1 ± 2.0 and 24.8 ± 2.0 kg/m2, respectively, in the H-BMI group (p < 0.001), whereas they were 21.7 ± 2.2 and 20.7 ± 2.2 kg/m2, respectively, in the N-BMI group (p = 0.007). There was significantly better differentiation (p = 0.034), less distant metastases (p = 0.006), and a lower metastatic lymph node ratio (p = 0.014) observed in the H-BMI groups. Multivariate analyses indicated age, BMI, pathological tumor depth, distant metastases, metastatic lymph node ratio, and tumor size as independent prognostic factors.


Our findings suggest that overweight patients were less likely to have tumors with aggressive features and can achieve ideal body weight following curative gastrectomy, possibly resulting in better long-term prognosis


Gastric carcinoma Curative gastrectomy Prognostic factors Body mass index 



We thank Debra Liu for critical reading of the manuscript. This work is supported by the Natural Science Foundation of China (no. 30901754 and no. 30901376) and Innovation Funding for Graduates of Tianjin Medical University, third Phase of the 211 Project for Higher Education (no. 2010GSI01).

Conflict of Interest

All authors have no potential conflicts of interest.


  1. 1.
    Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRefGoogle Scholar
  2. 2.
    Wang D, Zheng W, Wang SM, et al. Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China. Nutr Cancer. 2012;64:48–56.PubMedCrossRefGoogle Scholar
  3. 3.
    Kuriyama S. Impact of overweight and obesity on medical care costs, all-cause mortality, and the risk of cancer in Japan. J Epidemiol. 2006;16:139–44.PubMedCrossRefGoogle Scholar
  4. 4.
    Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1–452.Google Scholar
  5. 5.
    Kodera Y, Sasako M, Yamamoto S, et al. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg. 2005;92:1103–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Kodera Y, Ito S, Yamamura Y, et al. Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Hepatogastroenterology. 2004;51:1225–8.PubMedGoogle Scholar
  7. 7.
    Dhar DK, Kubota H, Tachibana M, et al. Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology. 2000;59:18–23.PubMedCrossRefGoogle Scholar
  8. 8.
    Inagawa S, Adachi S, Oda T, et al. Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer. Gastric Cancer. 2000;3:141–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Lee JH, Paik YH, Lee JS, et al. Abdominal shape of gastric cancer patients influences short-term surgical outcomes. Ann Surg Oncol. 2007;14:1288–94.PubMedCrossRefGoogle Scholar
  10. 10.
    Tokunaga M, Hiki N, Fukunaga T, et al. Better 5-year survival rate following curative gastrectomy in overweight patients. Ann Surg Oncol. 2009;16:3245–51.PubMedCrossRefGoogle Scholar
  11. 11.
    Jeon HG, Jeong IG, Lee JH, et al. Prognostic value of body mass index in Korean patients with renal cell carcinoma. J Urol. 2010;183:448–54.PubMedCrossRefGoogle Scholar
  12. 12.
    Murphy PM, Blackshaw GR, Paris HJ, et al. Prospective evaluation of nutritional status related to body mass indices and outcomes after modified D2 gastrectomy for carcinoma. Clin Nutr. 2004;23:477–83.PubMedCrossRefGoogle Scholar
  13. 13.
    Barry JD, Blackshaw GR, Edwards P, et al. Western body mass indices need not compromise outcomes after modified D2 gastrectomy for carcinoma. Gastric Cancer. 2003;6:80–5.PubMedGoogle Scholar
  14. 14.
    Tokunaga M, Hiki N, Fukunaga T, et al. Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br J Surg. 2009;96:496–500.PubMedCrossRefGoogle Scholar
  15. 15.
    Kim JW, Cheong JH, Hyung WJ, et al. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol. 2012;18:49–54.PubMedCrossRefGoogle Scholar
  16. 16.
    Adachi W, Kobayashi M, Koike S, et al. The influence of excess body weight on the surgical treatment of patients with gastric cancer. Surg Today. 1995;25:939–45.PubMedCrossRefGoogle Scholar
  17. 17.
    Nobuoka D, Gotohda N, Kato Y, et al. Influence of excess body weight on the surgical outcomes of total gastrectomy. Surg Today. 2011;41:928–34.PubMedCrossRefGoogle Scholar
  18. 18.
    Ojima T, Iwahashi M, Nakamori M, et al. Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: an analysis of 689 consecutive cases managed by a single center. Arch Surg. 2009;144:351–8. discussion 358.PubMedCrossRefGoogle Scholar
  19. 19.
    Szymanski D, Durczynski A, Strzelczyk J. Two-staged surgery for metastatic liver tumor in morbidly obese individual-left hemihepatectomy following placement of laparoscopic adjustable gastric band. Obes Surg. 2011;21:267–71.PubMedCrossRefGoogle Scholar
  20. 20.
    Srikanth MS, Fox SR, Oh KH, et al. Renal cell carcinoma following bariatric surgery. Obes Surg. 2005;15:1165–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Cox DR. Regression models and life-tables. J R Stat Soc Ser B Methodol. 1972;34(2):187–220.Google Scholar
  22. 22.
    Parr CL, Batty GD, Lam TH, et al. Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. Lancet Oncol. 2010;11:741–52.PubMedCrossRefGoogle Scholar
  23. 23.
    Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–105.PubMedCrossRefGoogle Scholar
  24. 24.
    Gabrielsen AM, Lund MB, Kongerud J, et al. The relationship between anthropometric measures, blood gases, and lung function in morbidly obese white subjects. Obes Surg. 2011;21:485–91.PubMedCrossRefGoogle Scholar
  25. 25.
    Tsujinaka T, Sasako M, Yamamoto S, et al. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol. 2007;14:355–61.PubMedCrossRefGoogle Scholar
  26. 26.
    Linebarger JH, Mathiason MA, Kallies KJ, et al. Does obesity impact lymph node retrieval in colon cancer surgery? Am J Surg. 2010;200:478–82.PubMedCrossRefGoogle Scholar
  27. 27.
    Oh SJ, Hyung WJ, Li C, et al. Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma. J Gastroenterol Hepatol. 2009;24:475–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Alici S, Kaya S, Izmirli M, et al. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med Sci Monit. 2006;12:CR221–9.PubMedGoogle Scholar
  29. 29.
    Matsuo T, Sairenchi T, Iso H, et al. Age- and gender-specific BMI in terms of the lowest mortality in Japanese general population. Obesity (Silver Spring). 2008;16:2348–55.CrossRefGoogle Scholar
  30. 30.
    Kiyama T, Mizutani T, Okuda T, et al. Postoperative changes in body composition after gastrectomy. J Gastrointest Surg. 2005;9:313–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Strain GW, Gagner M, Pomp A, et al. Comparison of weight loss and body composition changes with four surgical procedures. Surg Obes Relat Dis. 2009;5:582–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Parker AS, Lohse CM, Cheville JC, et al. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology. 2006;68:741–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Presti Jr JC, Lee U, Brooks JD, et al. Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population. J Urol. 2004;171:2199–202.PubMedCrossRefGoogle Scholar
  34. 34.
    Everett E, Tamimi H, Greer B, et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol. 2003;90:150–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Xiao LB, Yu JX, Wu WH, et al. Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. World J Gastroenterol. 2011;17:5123–30.PubMedCrossRefGoogle Scholar
  36. 36.
    Leggett MD, Chen SL, Schneider PD, et al. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann Surg Oncol. 2008;15:2493–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Lee SE, Lee JH, Ryu KW, et al. Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer. Hepatogastroenterology. 2012;59:430–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98:920–31.PubMedCrossRefGoogle Scholar
  39. 39.
    Haydon AM, Macinnis RJ, English DR, et al. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006;55:62–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Koch E, Bogado M, Araya F, et al. Impact of parity on anthropometric measures of obesity controlling by multiple confounders: a cross-sectional study in Chilean women. J Epidemiol Commun Health. 2008;62:461–70.CrossRefGoogle Scholar
  41. 41.
    Moore LL, Bradlee ML, Singer MR, et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord. 2004;28:559–67.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Fanming Kong
    • 1
    • 2
  • Hui Li
    • 2
  • Yongli Fan
    • 1
    • 2
  • Xinwei Zhang
    • 1
  • Shui Cao
    • 1
  • JinPu Yu
    • 2
  • Xiubao Ren
    • 1
    • 2
    Email author
  • Xishan Hao
    • 1
    • 2
    Email author
  1. 1.Department of BiotherapyTianjin Medical University Cancer Institute and HospitalTianjinChina
  2. 2.Key Laboratory of Cancer Prevention and TherapyTianjin Medical University Cancer Institute and HospitalTianjinChina

Personalised recommendations